Bamco Inc Astrazeneca PLC Transaction History

Bamco Inc

$35.2 Billion
Q2 2025

A detailed history of Bamco Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Bamco Inc holds 128,008 shares of AZN stock, worth $10.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

128,008

Previous 113,353 12.93%

Holding current value

$10.9 Million

Previous $8.33 Million 7.37%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $950,669 - $1.1 Million	14,655 Added 12.93%	128,008 $8.95 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $372,674 - $444,449	5,701 Added 5.3%	113,353 $8.33 Million
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $1.62 Million - $2.04 Million	-25,592 Reduced 19.21%	107,652 $7.05 Million
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $1.32 Million - $1.51 Million	-17,207 Reduced 11.44%	133,244 $10.4 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $935,139 - $1.13 Million	-13,997 Reduced 8.51%	150,451 $11.7 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $4.54 Million - $5.18 Million	-74,439 Reduced 31.16%	164,448 $11.1 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $648,500 - $717,000	10,000 Added 4.37%	238,887 $16.2 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $594,235 - $644,385	8,500 Added 3.86%	228,887 $16.4 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $6.6 Million - $7.48 Million	-104,484 Reduced 32.16%	220,387 $15.3 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $650,520 - $845,280	-12,000 Reduced 3.56%	324,871 $22 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $440,066 - $1.13 Million	8,300 Added 2.53%	336,871 $18.5 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $4.77 Million - $5.74 Million	85,563 Added 35.21%	328,571 $21.8 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $5.32 Million - $6.29 Million	98,500 Added 68.16%	243,008 $14.2 Million
Q1 2021 May 19, 2021	SELL	$47.16 - $54.44 $9.64 Million - $11.1 Million	-204,326 Reduced 58.57%	144,508 $7.19 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $905,819 - $1.08 Million	18,669 Added 5.65%	348,834 $17.4 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1.97 Million - $2.26 Million	37,061 Added 12.64%	330,165 $18.1 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $4.55 Million - $5.84 Million	105,601 Added 56.32%	293,104 $15.5 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $171,037 - $232,319	4,526 Added 2.47%	187,503 $8.37 Million
Q4 2019 Feb 18, 2020	BUY	$42.46 - $50.46 $88,019 - $104,603	2,073 Added 1.15%	182,977 $9.12 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $924,164 - $1.05 Million	23,035 Added 14.59%	180,904 $8.06 Million
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $957,052 - $1.07 Million	25,672 Added 19.42%	157,869 $6.52 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $1.82 Million - $2.2 Million	-51,192 Reduced 27.91%	132,197 $5.35 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $410,399 - $461,949	-11,134 Reduced 5.72%	183,389 $6.97 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $2.23 Million - $2.54 Million	64,023 Added 49.06%	194,523 $7.7 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $4.51 Million - $4.84 Million	130,500 New	130,500 $4.58 Million

Others Institutions Holding AZN

# of Institutions

1,412

Shares Held

496M

Call Options Held

7.11M

Put Options Held

2.56M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $265B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account